
The collaboration has expanded into a strategic partnership to build a dedicated AI supercomputer, which the companies describe as the most powerful AI factory for drug discovery.

The collaboration has expanded into a strategic partnership to build a dedicated AI supercomputer, which the companies describe as the most powerful AI factory for drug discovery.
Bristol Myers has purchased a new AI computing system from Nvidia to accelerate its drug discovery and research efforts. The hardware is designed to handle the massive computational requirements of modern pharmaceutical modeling. By leveraging specialized AI hardware, the company aims to reduce the time required for complex research tasks. This partnership underscores the growing demand for high-performance AI infrastructure in the life sciences sector. Will this hardware investment lead to faster drug development timelines for the company?